Assesses clinician readiness for amyloid-targeting therapies in Alzheimer's disease, suggesting educational improvements are effective.
To assess the impact of a multi-activity educational curriculum on clinician knowledge, skills, and real-world practice behaviors related to early diagnosis and the implementation of emerging disease-modifying and amyloid-targeting therapies (ATTs) in Alzheimer’s disease (AD).
No takes yet. Share an insight, caveat, or question.
Kriz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: